More about

Hepatitis B Virus

News
February 19, 2024
2 min read
Save

Gastroenterologists should ‘start to own,’ embrace role in care for chronic liver disease

Gastroenterologists should ‘start to own,’ embrace role in care for chronic liver disease

Chronic liver disease is the ninth leading cause of death in the United States, independent of liver cancer. According to the CDC, only 1.8% of adult Americans have a diagnosis of chronic liver disease, which translates to 4.5 million people.

News
February 05, 2024
1 min read
Save

Chronic HBV ‘positively associates’ with severe necroinflammation in pediatric MASLD

Chronic HBV ‘positively associates’ with severe necroinflammation in pediatric MASLD

Chronic hepatitis B virus infection was positively linked with severe hepatic necroinflammation in children with metabolic dysfunction-associated steatotic liver disease but did not appear to affect hepatic fibrosis, according to data.

News
December 07, 2023
2 min read
Save

Tenofovir disoproxil linked to better long-term outcomes vs. entecavir in HBV-related HCC

Tenofovir disoproxil linked to better long-term outcomes vs. entecavir in HBV-related HCC

Tenofovir disoproxil improved long-term overall and recurrence-free survival rates compared with entecavir among patients with hepatitis B virus-related hepatocellular carcinoma who underwent liver resection.

News
December 06, 2023
2 min read
Save

Drug use, unstable housing top risk factors during recent hepatitis A virus outbreak

Drug use, unstable housing top risk factors during recent hepatitis A virus outbreak

Nearly twice as many hepatitis A virus-related deaths were reported in the United States from 2016 to 2022 compared with the previous 6 years, with individuals who use drugs or experience homelessness and unstable housing most at risk.

News
November 27, 2023
1 min read
Save

Sofosbuvir/velpatasvir with tenofovir alafenamide efficacious for HCV, HBV co-infection

Sofosbuvir/velpatasvir with tenofovir alafenamide efficacious for HCV, HBV co-infection

BOSTON — After 12 weeks of treatment with sofosbuvir/velpatasvir in combination with tenofovir alafenamide, patients with hepatitis C virus and hepatitis B virus co-infection demonstrated high rates of sustained virologic response.

News
October 14, 2023
4 min read
Save

#OctoberIs4Livers campaign aims to ‘turn the tide’ during Liver Cancer Awareness Month

#OctoberIs4Livers campaign aims to ‘turn the tide’ during Liver Cancer Awareness Month

Liver Cancer Awareness Month, celebrated every October, seeks to raise awareness about the third deadliest cancer in the United States, with approximately 41,000 new cases and as many as 30,000 deaths each year.

News
September 05, 2023
1 min read
Save

First patient dosed in ISA’s phase 1 immunotherapy trial for chronic hepatitis B

First patient dosed in ISA’s phase 1 immunotherapy trial for chronic hepatitis B

ISA Pharmaceuticals announced that the first patient has been treated in its first-in-human phase 1 trial of its novel immunotherapeutic agent intended as a “functional cure” for patients with chronic hepatitis B virus infection.

News
August 24, 2023
2 min read
Save

Global HBV prevalence dips below 260 million; not ‘large enough’ for 2030 elimination goal

Global HBV prevalence dips below 260 million; not ‘large enough’ for 2030 elimination goal

Global burden of hepatitis B virus is estimated to be 257.5 million individuals, according to recent data in Lancet Gastroenterology & Hepatology, which, although lower than current WHO estimates, falls short of 2030 elimination targets.

News
August 15, 2023
3 min read
Save

Generic Baraclude, Viread for chronic HBV saved Medicare nearly $300M in 2020

Generic Baraclude, Viread for chronic HBV saved Medicare nearly $300M in 2020

Researchers estimated that the introduction of generic medications for chronic hepatitis B virus infection could save Medicare Part D nearly $300 million annually from the cost of medication alone, according to data in Gastroenterology.

News
August 14, 2023
2 min read
Save

Freeze-thaw embryo transfer safe for women with hepatitis B virus infection

Freeze-thaw embryo transfer safe for women with hepatitis B virus infection

Maternal hepatitis B virus serostatus was not associated with pregnancy outcomes in infertile women in China who underwent freeze-thaw embryo transfer, according to data in JAMA Network Open.

View more